• Publications
  • Influence
KLHL3 mutations cause familial hyperkalemic hypertension by impairing ion transport in the distal nephron
Familial hyperkalemic hypertension (FHHt) is a Mendelian form of arterial hypertension that is partially explained by mutations in WNK1 and WNK4 that lead to increased activity of the Na+-Cl−Expand
  • 133
  • 11
KLHL3 mutations cause familial hyperkalemic hypertension by impairing ion transport in the distal nephron
Hélène Louis-Dit-Picard, Julien Barc, Daniel Trujillano, Stéphanie Miserey-Lenkei, Nabila Bouatia-Naji, Olena Pylypenko, Geneviève Beaurain, Amélie Bonnefond, Olivier Sand, Christophe Simian,Expand
  • 102
  • 9
Amphotericin B nephrotoxicity.
The use of amphotericin B limited by dose-dependent nephrotoxicity. Elevated creatinine associated with amphotericin B is not only a marker for renal dysfunction, but is also linked to an increase inExpand
  • 239
  • 7
Risk factors of chronic kidney disease in HIV-infected patients.
BACKGROUND AND OBJECTIVES The main aim of this study was determining the risk factors of chronic kidney disease (CKD) in HIV-1-infected patients. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTSExpand
  • 76
  • 7
Erythropoietin enhances recovery after cisplatin-induced acute renal failure in the rat.
BACKGROUND Erythropoietin (Epo) is a growth factor whose synthesis mainly takes place in the kidney. Epo has been shown to support the growth not only of erythroid progenitor cells but also ofExpand
  • 128
  • 6
Outcome and prognosis factors in HIV-infected hemodialysis patients.
HIV-infected patients who are on hemodialysis have a worse prognosis than noninfected patients who are on hemodialysis. Their outcome in the highly active antiretroviral therapy (HAART) era remainsExpand
  • 59
  • 5
Bone mineral density and fracture prevalence in long-term kidney graft recipients
Background. Renal transplantation triggers an early bone loss that increases the subsequent risk of osteoporosis and fractures. Little is known about the long-term outcome of bone status and fractureExpand
  • 113
  • 2
CAPD with an amino acid dialysis solution: a long-term, cross-over study.
This prospective cross-over study was undertaken to evaluate the safety and efficacy of a 1% amino acid dialysis solution on the nutritional and metabolic changes, plasma amino acid profiles andExpand
  • 87
  • 2
Clopidogrel Activities in Patients with Renal Function Impairment
AbstractObjectives: To assess the tolerability, pharmacodynamic effects and pharmacokinetic parameters after repeated doses of clopidogrel (Plavix®) in patients with moderate or severe renal failure.Expand
  • 44
  • 1